Carrie Striker, DHEd, MPS, CCP, FPP

Clinical Assistant Professor

Milwaukee WI UNITED STATES
Electrical, Computer and Biomedical Engineering

Dr. Carrie Striker teaches in the MS Perfusion program with over 20 years’ experience in tertiary pediatric and congenital perfusion care.

Contact

Education, Licensure and Certification

D.H.Ed

Health Education

AT Still University

2011

M.P.S.

Perfusion Science

University of Nebraska Medical Center

2004

B.S.

Biomedical Engineering

Milwaukee School of Engineering

2001

Biography

Dr. Carrie Striker is a clinical assistant professor in the M.S. Perfusion program in the (ECBE) Electrical, Computer and Biomedical Engineering department. She has been a faculty member at MSOE since 2024.

She is a Certified Clinical Perfusionist with 20 years’ experience providing services ranging from tertiary pediatric care to tertiary and community adult care. She is practiced in cardiopulmonary bypass techniques for a wide array of surgical procedures and is experienced in Extracorporeal Life Support methods and techniques.

Striker is a pediatric and congenital cardiovascular perfusionist at Childrens Wisconsin and formerly was a pediatric and congenital cardiovascular perfusionist at the Cincinnati Children's Hospital Medical Center's Joint Pediatric Heart Care Program with the University of Kentucky. Striker is a published author, researcher, and a dedicated educator committed to providing comprehensive clinical and didactic instruction.

She previously served as innovator and program director for the Pediatric and Congenital Cardiovascular Perfusion Fellowship Program at Children’s Mercy Hospital and the corresponding graduate certificate at University of Missouri Kansas City. She has also served on national and hospital committees and supervised graduate students in the development, implementation, and publication of research.

Areas of Expertise

Cardiovascular Perfusion

Pediatric Perfusion

Congenital Perfusion

Cardiopulonary Bypass

Researcher

Accomplishments

Inquiry & Innovation Awards for Nursing and Allied Health

2015-05-27

Children’s Mercy Hospital, Kansas City, Missouri

Golden Apple Mercy Mentor

2016-06-09

Children’s Mercy Hospital, Kansas City, Missouri

Selected Publications

Evaluating the need for magnesium administration following cardioplegic arrest with del Nido cardioplegia solution

J Extra Corpor Technol

Striker CW & Reagor JA

2025

Background: del Nido cardioplegia (dNC) solution is widely used in pediatric and congenital cardiac surgery. In 2014, Cincinnati Children’s Hospital Medical Center (CCHMC) changed from Mee cardioplegic solution to dNC. Since Mee solution does not contain magnesium, magnesium was administrated post cross-clamp removal, at a dose of 25 mg/kg up to 1 g, to abate hypomagnesemia. This practice remained in place with the use of dNC. We postulated that patients may experience hypermagnesemia under this protocol. Methods: To determine if exogenous magnesium is necessary post-clamp removal in our practice, a study examining serum magnesium levels during cardiopulmonary bypass (CPB) was completed from January 2022 through October 2023 (IRB #2021-0816). One hundred patients undergoing CPB with cross-clamp, ranging from infants to adults, were consented. Two magnesium samples were collected. Draw 1 (D1) was collected post cardioplegia administration and 30 min prior to cross-clamp removal. Draw 2 (D2) was collected post-cross-clamp removal and 10 ± 2 min following magnesium administration. Results: Both samples demonstrated magnesium levels > 1.6 mg/dL or higher (normal magnesium range at CCHMC, 1.6–2.6 mg/dL). A Wilcoxon rank sum test demonstrated statistical significance for D1, comparing the number of samples that fell above 2.6 mg/dL vs. those that fell within the normal range (p < 0.001). D2 demonstrated values above the normal range for all but one sample, which does not satisfy the criteria of the Wilcoxon rank sum test for demonstrating significance (p = 0.089); however, ninety-nine samples displayed hypermagnesemia. Conclusion: This study demonstrates that exogenous magnesium administration may not be necessary in the setting of our practice at CCHMC and dNC cardioplegic arrest.

del Nido versus St. Thomas Cardioplegia Solutions: A Single-Center Retrospective Analysis of Post Cross-Clamp Defibrillation Rates

Journal of ExtraCorporeal Technology

Buel S, Striker C, O’Brien J.

2016-06-01

There are many cardioplegia solutions currently in use for pediatric cardiopulmonary bypass (CPB). The most common being del Nido solution. Another common cardioplegia solution used for pediatric CPB is St. Thomas. In October 2014, Children's Mercy Kansas City changed from the use of modified St. Thomas to del Nido. This study compared rates of post cross-clamp fibrillation requiring defibrillation between del Nido solution and modified St. Thomas solution stratified by weight at Children's Mercy Kansas City.